MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, today announced the appointment of Dr Julia Wright, MD, FACP, as its new Chief Medical Officer (CMO). Dr Julia ...

Review of the Best Phentermine Over the Counter Alternatives 2023 That Really Work) Phentermine, a prescription weight loss medication, operates by suppressing one’s appetite, often ...

Read about Moon Surgical news regarding the latest FDA clearance for groundbreaking tech enhancing surgical precision and AI integration in healthcare.

Psychologist having session with her female patient in her private consulting room If you still need more convincing about the potential benefits of counseling for healthcare workers, read the ...

Avania will evolve, invest, and pivot with the industry so it can achieve its mission of partnering with MedTech sponsors to bring life-changing technology to market, resulting in improved healthcare ...

Donald A. Balasa, JD, MBA, CEO, and House Legal Counsel, American Association of Medical Assistants writes about the significant changes in laws and standards that have empowered medical assistants to ...

Genome Canada funds ClarityDX Prostate test to enhance prostate cancer diagnostics in Canadian healthcare.

Being a doctor or healthcare professional involves more than knowing a great deal about medical and health issues and treatments. Many patients feel nervous about coming to see a healthcare ...

Geometric Tolerances defines the dimensions of medical tools and devices with a range of tolerances and clearances. Read on to learn more.

The VELYS SPINE system is designed to address the uniquely complex needs of spine surgeons; the system offers a customizable experience with pathology-specific workflows, aided by capabilities such as ...

The second phase of the ADVANTAGE AF study shows positive results for the FARAPULSE Pulsed Field Ablation System in treating atrial fibrillation.

EXPAND is a prospective, randomized, single-blind, intra-patient controlled, post-market clinical trial enrolling approximately 80 patients in the United States.